Stock Track | Exact Sciences Soars 5.05% on Monday Amid Investor Conference Participation and Analyst Rating

Stock Track02-24

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.

Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.

Additionally, Scotiabank maintained its "Sector Outperform" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182320766?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-25 01:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182320766","market":"us","top_or_hot":-1,"title":"Stock Track | Exact Sciences Soars 5.05% on Monday Amid Investor Conference Participation and Analyst Rating","media":"Stock Track","content":"<p>Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.</p>\n\n<p>Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.</p>\n\n<p>Additionally, Scotiabank maintained its \"Sector Outperform\" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Exact Sciences Soars 5.05% on Monday Amid Investor Conference Participation and Analyst Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Exact Sciences Soars 5.05% on Monday Amid Investor Conference Participation and Analyst Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-25 01:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.</p>\n\n<p>Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.</p>\n\n<p>Additionally, Scotiabank maintained its \"Sector Outperform\" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EXAS","symbol_name":"精密科学","start_time":0,"source_url":"","article_id":"1182320766","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182320766","pubTimestamp":1740418961,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. Du","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EXAS":"精密科学"},"translate_title":"由于投资者会议参与和分析师评级，股票跟踪Exact Sciences周一飙升5.05%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EXAS":1},"content_text":"Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.\nExact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.\nAdditionally, Scotiabank maintained its \"Sector Outperform\" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182320766"}